Tinurilimab
Catalogue number:
HY-P99051-5mg
Supplier:
Size:
5 mg
Product is available in:
Applications:
COVID-19-immunoregulation
Target:
Transmembrane Glycoprotein
Alternative Names:
BAY 1834942
- Data sheet: View or download
- MSDS: View or download
- Protocol: View or download
Product Description:
Tinurilimab (Bay 1834942) is an anti-CEACAM6 (carcinoembryonic antigen-related cell adhesion molecule 6) humanized IgG2 monoclonal antibody. CEACAM6 is an immune checkpoint regulator suppressing the activity of effector T-cells against tumors. Tinurilimab shows an increased tumor cell killing effect in the tumor-cell/T-cell co-culture system[1].